Surgery · Breast (Benign, Carcinoma Breast, Staging, Treatment)

A 65-year-old woman with a 1.2 cm ER-positive, HER2-negative, node-negative invasive ductal carcinoma undergoes breast-conserving surgery with negative margins. She is postmenopausal and has no comorbidities. According to the PRIME II trial, which statement about adjuvant radiotherapy is correct?

  • A Radiotherapy is mandatory regardless of risk factors
  • B Radiotherapy can be safely omitted in this low-risk group
  • C Radiotherapy is indicated only if margins are positive
  • D Radiotherapy should be replaced by chemotherapy
Correct answer: B. Radiotherapy can be safely omitted in this low-risk group

Explanation

The PRIME II trial demonstrated that omission of adjuvant radiotherapy in low-risk patients, age 65 or older, T1, ER-positive, node-negative, margins negative, results in a small increase in local recurrence but no difference in overall survival. Radiotherapy can be safely omitted in this group after discussion.

Reference: Harrison Principles of Internal Medicine, 21st ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Breast (Benign, Carcinoma Breast, Staging, Treatment) MCQs

See all Breast (Benign, Carcinoma Breast, Staging, Treatment) MCQs →